Digital repository of Slovenian research organisations

Search the repository
A+ | A- | Help | SLO | ENG

Query: search in
search in
search in
search in

Options:
  Reset


Query: "keywords" (rak) .

11 - 20 / 1483
First pagePrevious page12345678910Next pageLast page
11.
35. onkološki vikend : umetna inteligenca v onkologiji in spremljanje bolnikov z rakom po zaključenem zdravljenju
2024, proceedings of professional or unreviewed scientific conference contributions

Keywords: rak, onkologija, nacionalni programi, državni program obvladovanja raka (DPOR), umetna inteligenca, imunoterapija, zborniki
Published in DiRROS: 16.05.2024; Views: 143; Downloads: 314
.pdf Full text (15,25 MB)
This document has many files! More...

12.
Poročilo o preskusu št.: LVG 2024-00095 : vzorec št. 12179633
Nikica Ogris, Špela Hočevar, Barbara Piškur, 2024, expertise, arbitration decision

Keywords: varstvo gozdov, morfološke analize, platana, Platanus x hispanica, bolezen drevesa, rakasta razjeda, rak, Phomopsis, Diaporthe
Published in DiRROS: 10.05.2024; Views: 187; Downloads: 0
This document has many files! More...

13.
CA19-9 serum levels predict micrometastases in patients with gastric cancer
Tomaž Jagrič, Stojan Potrč, Katarina Miš, Mojca Plankl, Tomaž Marš, 2016, original scientific article

Abstract: Background. We explored the prognostic value of the up-regulated carbohydrate antigen (CA19-9) in node-negative patients with gastric cancer as a surrogate marker for micrometastases. Patients and methods. Micrometastases were determined using reverse transcription quantitative polymerase chain reaction (RT-qPCR) for a subgroup of 30 node-negative patients. This group was used to determine the cut-off for preoperative CA19-9 serum levels as a surrogate marker for micrometastases. Then 187 node-negative T1 to T4 patients were selected to validate the predictive value of this CA19-9 threshold. Results. Patients with micrometastases had significantly higher preoperative CA19-9 serum levels compared to patients without micrometastases (p = 0.046). CA19-9 serum levels were significantly correlated with tumour site, tumour diameter, and perineural invasion. Although not reaching significance, subgroup analysis showed better five-year survival rates for patients with CA19-9 serum levels below the threshold, compared to patients with CA19-9 serum levels above the cut-off. The cumulative survival for T2 to T4 node-negative patients was significantly better with CA19-9 serum levels below the cut-off (p = 0.04). Conclusions. Preoperative CA19-9 serum levels can be used to predict higher risk for haematogenous spread and micrometastases in node-negative patients. However, CA19-9 serum levels lack the necessary sensitivity and specificity to reliably predict micrometastases.
Keywords: gastric cancer, micrometastases, CA19-9, rak (medicina), želodec, metastaze, diagnostika, antigeni, tumorski označevalci
Published in DiRROS: 09.05.2024; Views: 137; Downloads: 120
.pdf Full text (793,76 KB)
This document has many files! More...

14.
15.
Nova zdravila za tarčno zdravljenje pljučnega raka z insercijo v eksonu 20 gena EGFR : klinični primer
Aleksandra Sokolova, Loredana Mrak, 2024, published professional conference contribution

Keywords: internistična onkologija, pljučni rak, kemoterapija
Published in DiRROS: 22.04.2024; Views: 165; Downloads: 40
.pdf Full text (861,94 KB)

16.
Uporaba sacituzumab-govitekana pri predhodno močno zdravljeni bolnici z razsejanim trojno negativnim rakom dojk
Nina Privšek, Cvetka Grašič-Kuhar, 2024, published professional conference contribution

Keywords: internistična onkologija, rak dojk, kemoterapija
Published in DiRROS: 22.04.2024; Views: 155; Downloads: 39
.pdf Full text (875,62 KB)

17.
Rak telesa maternice : vzdrževalno zdravljenje z navtemadlinom, zaviralcem MDM2
Ana Geltar, Erik Škof, 2024, published professional conference contribution

Keywords: internistična onkologija, rak telesa maternice, kemoterapija
Published in DiRROS: 22.04.2024; Views: 144; Downloads: 44
.pdf Full text (903,42 KB)

18.
19.
Zdravljenje bolnice z metastatskim urotelnim karcinomom ledvičnega meha s sodobnimi onkološkimi zdravili
Mićo Božić, Tanja Ovčariček, 2024, published professional conference contribution

Keywords: internistična onkologija, rak ledvic, kemoterapija
Published in DiRROS: 22.04.2024; Views: 166; Downloads: 47
.pdf Full text (735,88 KB)

20.
Teranostično zdravljenje - nov pristop v zdravljenju napredovalega raka prostate
Daša Bosilj, Tina Pavlin, Boštjan Šeruga, 2024, published professional conference contribution

Keywords: internistična onkologija, rak prostate, kemoterapija
Published in DiRROS: 22.04.2024; Views: 180; Downloads: 40
.pdf Full text (888,27 KB)

Search done in 0.42 sec.
Back to top